In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, IOL Chemicals and Pharmaceuticals has informed that the next meeting of the Board of Directors is scheduled to be held on Friday, the 12th November 2021 to consider and approve the Audited Financial Results of the Company for the Quarter and half year ended 30th September 2021. Further, pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's ‘Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons’, the Trading Window which is closed with effect from 01st October 2021 shall continue to close till the expiry of 48 hours from the date of financial results for Quarter and half year ended 30th September 2021 are made public. Accordingly, the trading window shall reopen on 15th November 2021.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: